Effect of antidepressant treatment on peripheral inflammation markers – A meta-analysis

@article{Widocha2018EffectOA,
  title={Effect of antidepressant treatment on peripheral inflammation markers – A meta-analysis},
  author={Magdalena Więdłocha and Piotr Marcinowicz and Renata Krupa and Marlena Janoska-Jaździk and Marta Janus and Weronika Dębowska and Anna Mosiołek and Napoleon Waszkiewicz and Agata Szulc},
  journal={Progress in Neuro-Psychopharmacology and Biological Psychiatry},
  year={2018},
  volume={80},
  pages={217-226}
}
INTRODUCTION Major Depressive Disorder (MDD) in accordance to the inflammatory concept is associated with complex immunological disturbances in the central nervous system (CNS). This is reflected by elevated plasma levels of inflammatory cytokines in depressed subjects. Although numerous studies report significant influence of antidepressants on pro-inflammatory/anti-inflammatory cytokines balance, the available data is often inconsistent regarding specific cytokines and drugs used. We aimed to… Expand
The relationship between plasma cytokine levels and antidepressant response in patients with first-episode major depressive disorder.
TLDR
A range of cytokines were abnormal in patients with first-episode drug naïve MDD and most of the cytokines could be normalized after antidepressant treatment, and baseline ITAC level could be a predictive factor of antidepressant response. Expand
Effects of Antidepressant Treatment on Peripheral Biomarkers in Patients with Major Depressive Disorder (MDD)
TLDR
Emergent evidence indicates that MDD is related to disturbed neurogenesis and suggests a possible role of neurotrophic factors in recovery of function in patients, and emerging data regarding the influence of different antidepressant drugs on a wide array of peripheral biomarkers such as interleukin (IL-1ß), IL-2, IL-5, ILs, or interferon (IFN)-γ are outlined. Expand
Immune-based strategies for mood disorders: facts and challenges
TLDR
The evidence showing low-grade inflammation in mood disorders and the studies evaluating immune-based strategies for the treatment of these conditions are reviewed. Expand
Different levels of pro- and anti-inflammatory cytokines in patients with unipolar and bipolar depression.
TLDR
Even within the same depressive states, MDD and BDD patients present different inflammatory features, particularly in regard to pro-inflammatory TNF-α and anti-inflammatory IL-13, and the fluctuations of cytokines induced by medication may provide a hint regarding the prediction of treatment response. Expand
Alterations of multiple peripheral inflammatory cytokine levels after repeated ketamine infusions in major depressive disorder
TLDR
The results suggest that the inflammatory pathway may be involved in the antidepressant effects of ketamine, which may be conducive to future treatment strategy optimization. Expand
Targeting cytokines in reduction of depressive symptoms: A comprehensive review
TLDR
The use of anti‐inflammatories show promise for disease modifying effects that may alter illness trajectory, rather than solely ameliorating current mood symptoms, as shown in clinical trials assessing the effects of cytokine blockers for depression and depressive symptoms. Expand
Basal and LPS-stimulated inflammatory markers and the course of individual symptoms of depression
TLDR
It is found that basal and LPS-stimulated inflammatory markers were more strongly associated with sickness behavior symptoms at up to 9-year follow-up compared with non-sickness behavior symptoms of depression. Expand
Neuroinflammation and depression
TLDR
The evidence of the coexistence of peripheral low-grade inflammation and neuroinflammation and their effects on brain function and possible causes in depression is reviewed. Expand
Depression and the Effect of Sertraline on Inflammatory Biomarkers in Patients with Nondialysis CKD
TLDR
Among patients with CKD and MDD, hsCRP correlated with somatic symptoms of depression and fatigue, but not with non-somatic symptoms, and those who failed to respond to placebo had an increase in hs CRP over time. Expand
Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation
TLDR
In conclusion, inflammatory markers offer the potential not only to personalize antidepressant prescription but also to guide the development of novel mechanistically-guided antidepressant treatments. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 59 REFERENCES
The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis
TLDR
Overall, while pharmacological antidepressant treatment reduced depressive symptoms, it did not reduce serum levels of TNFα, but antidepressant treatment did reduce levels of IL-1β and possibly those ofIL-6, which are consistent with the possibility that inflammatory cytokines contribute to depressive symptoms and that antidepressants block the effects ofinflammatory cytokines on the brain. Expand
Effect of Selective Serotonin Reuptake Inhibitors and Immunomodulator on Cytokines Levels: An Alternative Therapy for Patients with Major Depressive Disorder
TLDR
The results suggest that the immune-stimulating activity of hDLE, in combination with SSRIs, restored the pro- and anti-inflammatory cytokine balance and cortisol levels in depressed patients versus those who were given SSR Is alone. Expand
Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder
Abstract Alterations in the immune system may have importance for the pathophysiology of depression. Several studies have linked increased production of pro-inflammatory cytokines to depression andExpand
A Meta-Analysis of Cytokines in Major Depression
TLDR
A meta-analysis of studies measuring cytokine concentration in patients with major depression reports significantly higher concentrations of the proinflammatory cytokines TNF-alpha and IL-6 in depressed subjects compared with control subjects, strengthening evidence that depression is accompanied by activation of the IRS. Expand
Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder
TLDR
The results suggest that depressed patients only reach a partial reestablishment of HPA axis function after the long-term administration of SSRI. Expand
Pro- and Anti-Inflammatory Cytokine Balance in Major Depression: Effect of Sertraline Therapy
TLDR
The results indicate that Th1-, Th2-, and Th3-type cytokines are altered in the depressed patients and some of them might have been corrected by sertraline treatment. Expand
Connection between inflammatory markers, antidepressants and depression.
TLDR
Results pointed to the efficacy of antidepressant therapy for depression by reducing the concentration of C-reactive protein, a statistically significant difference between the group of MDD subjects and control group of healthy subjects. Expand
Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds.
TLDR
In accordance to early clinical response, duloxetine treatment could divide depressed patients into at least 2 subgroups characterized by clinical and laboratory differentiated behavior, suggesting different neurobiological background within depressive syndrome differentially sensitive to different drug components. Expand
Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis
TLDR
There may be a normalization of overactive inflammatory processes following antidepressant treatment, according to a meta-analysis of studies which reported circulating levels of inflammatory markers before and after antidepressant treatment for people with depression. Expand
Pro-inflammatory biomakers in depression: Treatment with venlafaxine
  • J. Piletz, A. Halaris, +5 authors C. DeVane
  • Psychology, Medicine
  • The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • 2009
TLDR
A concave quadratic equation described the associations between plasma venlafaxine concentrations and IL1β, T NFα, TNFα, and MCP-1, suggesting that these biomarkers may have become selectively lowered in the serotonergic dose range of venl Lafaxine. Expand
...
1
2
3
4
5
...